NFKB1 and colorectal carcinoma: Further, it has been shown that constitutive activation of “NFKB” instigates strong resistance to chemotherapy and radiotherapy [67], while molecular targeted therapy against “NFKB” activation is believed to be effective in colorectal carcinomas with constitutive “NFKB” activation [59].